Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

References

• Soyka M. Treatment of Benzodiazepine Dependence. N Engl J Med. 2017;376(12):1147–1157. doi:10.1056/NEJMra161183228328330
   PubMed Web of Science ®Google Scholar
• Takano A, Ono S, Yamana H, et al. Factors associated with long-term prescription of benzodiazepine: a retrospective cohort study using a health insurance database in Japan. BMJ Open. 2019;9(7):e029641. doi:10.1136/bmjopen-2019-029641
   Web of Science ®Google Scholar
• Enomoto M, Kitamura S, Tachimori H, Takeshima M, Mishima K. Long-term use of hypnotics: analysis of trends and risk factors. Gen Hosp Psychiatry. 2020;62:49–55. doi:10.1016/j.genhosppsych.2019.11.00831786448
   PubMed Web of Science ®Google Scholar
• Magnusdottir SD, Ribacke M. Patients’ knowledge and attitudes regarding sleep and hypnotics. Scand J Prim Health Care. 1996;14(2):106–110. doi:10.3109/028134396089970798792504
   PubMed Web of Science ®Google Scholar
• Liebrenz M, Gehring MT, Buadze A, Caflisch C. High-dose benzodiazepine dependence: a qualitative study of patients’ perception on cessation and withdrawal. BMC Psychiatry. 2015;15:116. doi:10.1186/s12888-015-0493-y25968120
   PubMed Web of Science ®Google Scholar
• Williams F, Mahfouz C, Bonney A, et al. A circle of silence: the attitudes of patients older than 65 years of age to ceasing long-term sleeping tablets. Aust Fam Physician. 2016;45(7):506–511.27610435
   PubMedGoogle Scholar
• Anthierens S, Pasteels I, Habraken H, Steinberg P, Declercq T, Christiaens T. Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: family physicians’ attitudes toward benzodiazepine prescribing. Can Fam Physician. 2010;56(11):e398–406.21075981
   PubMed Web of Science ®Google Scholar
• Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 2015;69(8):440–447. doi:10.1111/pcn.1227525601291
   PubMed Web of Science ®Google Scholar
• Blennow G, Romelsjö A, Leifman H, Leifman A, Karlsson G. Sedatives and hypnotics in Stockholm: social factors and kinds of use. Am J Public Health. 1994;84(2):242–246. doi:10.2105/AJPH.84.2.2428296948
   PubMed Web of Science ®Google Scholar
• Neutel CI. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry. 2005;17(3):189–197. doi:10.1080/0954026050007186316194790
   PubMed Web of Science ®Google Scholar
• Stowell KR, Chang CC, Bilt J, Stoehr GP, Ganguli M. Sustained benzodiazepine use in a community sample of older adults. J Am Geriatr Soc. 2008;56(12):2285–2291. doi:10.1111/j.1532-5415.2008.02011.x19093928
   PubMed Web of Science ®Google Scholar
• de Las Cuevas C, Sanz E, de la Fuente J. Benzodiazepines: more “behavioural” addiction than dependence. Psychopharmacology. 2003;167(3):297–303. doi:10.1007/s00213-002-1376-812669174
   PubMed Web of Science ®Google Scholar
• Elvik R. Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev. 2013;60:254–267. doi:10.1016/j.aap.2012.06.01722785089
   PubMed Web of Science ®Google Scholar
• Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet. 1998;352(9137):1331–1336. doi:10.1016/S0140-6736(98)04087-29802269
   PubMed Web of Science ®Google Scholar
• Dassanayake T, Michie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf. 2011;34(2):125–156. doi:10.2165/11539050-000000000-0000021247221
   PubMed Web of Science ®Google Scholar
• Tanaka E. Toxicological interactions between alcohol and benzodiazepines. J Toxicol Clin Toxicol. 2002;40(1):69–75. doi:10.1081/CLT-12000288711990206
   PubMed Web of Science ®Google Scholar
• Uchida T, Hirano J, Sakurai H, Suzuki T, Mimura M, Uchida H. Concomitant use of alcohol and benzodiazepine hypnotics in psychiatric outpatients: a cross-sectional survey. Int Clin Psychopharmacol. 2019;34(6):291–297. doi:10.1097/YIC.000000000000026430998597
   PubMed Web of Science ®Google Scholar
• Breilmann J, Girlanda F, Guaiana G, et al. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database Syst Rev. 2019;3:CD010677. doi:10.1002/14651858.CD010677.pub230921478
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. American Psychiatric Association Practice Guideline for the Treatment of Panic Disorder. American Psychiatric Publishing; 2009. Available from: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf. Accessed 143 2021.
   Google Scholar
• National Institute for Health and Care Excellence. Generalised Anxiety Disorder and Panic Disorder (With or Without Agoraphobia) in Adults (CG113); 2011. Available from: https://www.nice.org.uk/guidance/cg113. Accessed 143 2021.
   Google Scholar
• Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(5):403–439. doi:10.1177/026988111452567424713617
   PubMed Web of Science ®Google Scholar
• Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 Suppl 1(Suppl1):S1. doi:10.1186/1471-244X-14-S1-S125081580
   PubMed Web of Science ®Google Scholar
• Uchida H, Suzuki T, Mamo DC, et al. Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan. J Anxiety Disord. 2009;23(4):477–481. doi:10.1016/j.janxdis.2008.10.00319010641
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Takeshima N, Hayasaka Y, et al. Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database Syst Rev. 2019;6:CD001026. doi:10.1002/14651858.CD001026.pub231158298
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Depression in adults with a chronic physical health problem: recognition and management (CG90); 2009. Available from: https://www.nice.org.uk/guidance/CG90. Accessed 143 2021.
   Google Scholar
• Cleare A, Pariante CM, Young AH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29(5):459–525. doi:10.1177/026988111558109325969470
   PubMed Web of Science ®Google Scholar
• Bauer M, Severus E, Möller HJ, Young AH. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines. Int J Psychiatry Clin Pract. 2017;21(3):166–176. doi:10.1080/13651501.2017.130608228367707
   PubMed Web of Science ®Google Scholar
• Watanabe N, Churchill R, Furukawa TA. Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database Syst Rev. 2009;3(1):Cd005335.
   Google Scholar
• Mishima K. Outline of the revision of medical service fees for preventing polypharmacy and long-term prescription of psychotropic drugs and its clinical background. Seishin Igaku. 2020;62(4):365–375.
   Google Scholar
• Svensson SA, Hedenrud TM, Wallerstedt SM. Attitudes and behaviour towards psychotropic drug prescribing in Swedish primary care: a questionnaire study. BMC Fam Pract. 2019;20(1):4. doi:10.1186/s12875-018-0885-430611211
   PubMed Web of Science ®Google Scholar
• Oldenhof E, Anderson-Wurf J, Hall K, Staiger PK. Beyond Prescriptions Monitoring Programs: the Importance of Having the Conversation about Benzodiazepine Use. J Clin Med. 2019;8(12):12. doi:10.3390/jcm8122143
   Web of Science ®Google Scholar
• Di Lorenzo R, Perrone D, Montorsi A, Balducci J, Rovesti S, Ferri P. Attitude Towards Drug Therapy in a Community Mental Health Center Evaluated by the Drug Attitude Inventory. Patient Prefer Adherence. 2020;14:995–1010. doi:10.2147/PPA.S25199332606616
   PubMed Web of Science ®Google Scholar
• Willems IA, Gorgels WJ, Oude Voshaar RC, Mulder J, Lucassen PL. Tolerance to benzodiazepines among long-term users in primary care. Fam Pract. 2013;30(4):404–410. doi:10.1093/fampra/cmt01023515374
   PubMed Web of Science ®Google Scholar